• No results found

Epidemiological Aspects on Assessing and Treating Dyslipidemia in Type 1 Diabetes

N/A
N/A
Protected

Academic year: 2021

Share "Epidemiological Aspects on Assessing and Treating Dyslipidemia in Type 1 Diabetes"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Epidemiological Aspects

on Assessing and Treating

Dyslipidemia in Type 1 Diabetes

Studies from the Swedish National

Diabetes Register

Christel Hero

Epidemiological

Aspects on

Assessing and

T

reating Dyslipidemia in

T

ype 1 Diabetes | Christel Hero

ISBN 978-91-7833-714-9 (PRINT) ISBN 978-91-7833-715-6 (PDF) http://hdl.handle.net/2077/62216 Printed by BrandFactory, Gothenburg

References

Related documents

The second study “Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study” investigated the risk for development of heart

After adjustment for initial pain severity, other associated symptoms, and mental health, persons who thought they were less likely to make a full recovery were more likely to

We investigated the strength of association for risk factors and varying levels of glycated hemoglobin, systolic blood pressure and low-density lipoprotein cholesterol

In addition, we aimed to examine the effect of multifactorial risk factor control, as well as optimal levels- and relative importance of cardiovascular risk factors, in patients

Epidemiological Aspects of Cardiovascular Morbidity and Mortality Among Individuals with Diabetes. |

Decreased in systolic blood pressure during follow up is associated with an increased risk of all-cause mortality in patients with type 2-diabetes and renal impairment-a

Decreased in systolic blood pressure during follow up is associated with an increased risk of all-cause mortality in patients with type 2-diabetes and renal impairment-a

Hero C, Rawshani A, Svensson A-M, Franzén S, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death